ScholarIQanswers from OpenAlex & ORCID
John Bradley
ResearcherPublications, citations & collaboration network
John Bradley is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John Bradley have?
ScholarIQindexed works
John Bradley has 403 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John Bradley have?
ScholarIQcitation count
John Bradley has 17,938 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John Bradley?
ScholarIQh-index
John Bradley has an h-index of 59 in OpenAlex.
What is the i10-index of John Bradley?
ScholarIQi10-index
John Bradley has an i10-index of 180 in OpenAlex.
What is the ORCID of John Bradley?
ScholarIQorcid
The ORCID for John Bradley is on the source record.
What is the OpenAlex record for John Bradley?
ScholarIQopenalex
The OpenAlex for John Bradley is on the source record.
What are the most-cited papers on John Bradley?
ScholarIQmost cited works
Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis
Daniel O. Clegg, Domenic J. Reda, Crystal L. Harris, Marguerite Klein, James R. O’Dell, Michele Hooper, John Bradley, Clifton O. Bingham, Michael H. Weisman, Christopher G. Jackson, Nancy E. Lane, John J. Cush, Larry W. Moreland, H. Ralph Schumacher, Chester V. Oddis, Frederick Wolfe, Jerry A. Molitor, David E. Yocum, Thomas J. Schnitzer, Daniel E. Furst, Allen D. Sawitzke, Helen Shi, Kenneth D. Brandt, Roland W. Moskowitz, H. James Williams
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann, Joel M. Kremer, John J. Cush, Hendrik Schulze‐Koops, Carol A. Connell, John Bradley, David Gruben, Gene V. Wallenstein, Samuel H. Zwillich, Keith S. Kanik
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald van Vollenhoven, Roy Fleischmann, Stanley Cohen, Eun Bong Lee, Juan A. García Meijide, Sylke Wagner, Šárka Forejtová, Samuel H. Zwillich, David Gruben, Tamás Koncz, Gene V. Wallenstein, Sriram Krishnaswami, John Bradley, Bethanie Wilkinson
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Eun Bong Lee, Roy Fleischmann, Stephen Hall, Bethanie Wilkinson, John Bradley, David Gruben, Tamás Koncz, Sriram Krishnaswami, Gene V. Wallenstein, Chuanbo Zang, Samuel H. Zwillich, Ronald van Vollenhoven
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman, J. Wollenhaupt, Cristiano A. F. Zerbini, Birgitta Benda, David Gruben, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, Tamás Koncz, Koshika Soma, John Bradley, Charles A. Mebus